Colgate-Palmolive (CL) files notice to resell 161,021 shares via option exercise

Rhea-AI Filing Summary

Colgate-Palmolive Co. is the issuer in a planned resale of its common stock, with a notice covering up to 161,021 shares. The shares are to be sold through Merrill Lynch in a broker-assisted cashless exercise of employee stock options, with an indicated aggregate market value of $14,800,720.47. The securities, identified by CUSIP 797172829, are listed on the NYSE, and the proposed sale date is August 4, 2026.

Key Figures

Shares covered: 161,021 shares Aggregate market value: $14,800,720.47 Proposed sale date: 08/04/2026 +1 more

4 metrics

Shares covered 161,021 shares Maximum Colgate-Palmolive common stock shares in the proposed resale

Aggregate market value $14,800,720.47 Indicated value of the shares covered by the notice

Proposed sale date 08/04/2026 Date for the broker-assisted cashless exercise and related sale

CUSIP 797172829 Identifier for Colgate-Palmolive common stock listed on NYSE

Key Terms

Form 144, broker assisted cashless exercise, employee stock options, aggregate market value

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

broker assisted cashless exercise financial

"161021 | 08/04/2026 | Broker assisted cashless exercise"

employee stock options financial

"Exercise of employee stock options | COLGATE PALMOLIVE CO"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

aggregate market value financial

"161021 | 14800720.47 | 797172829 | 08/04/2026 | NYSE"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:40 PM Accepted by SEC EDGAR 08/04/2026 - 04:39 PM Learn about SEC filing dates

FAQ

What does Colgate-Palmolive (CL) disclose in this Form 144 notice?

The notice covers a proposed resale of up to 161,021 shares of Colgate-Palmolive common stock via a broker-assisted cashless exercise of employee stock options, with an aggregate market value of $14,800,720.47 and a proposed sale date of August 4, 2026.

How many Colgate-Palmolive (CL) shares are covered and what is their value?

The filing covers up to 161,021 shares of Colgate-Palmolive common stock. The indicated aggregate market value for these shares is $14,800,720.47, based on the figures stated in the notice of proposed sale.

What is the method of sale for the Colgate-Palmolive (CL) shares in this filing?

The shares are expected to be sold through a broker assisted cashless exercise of employee stock options. Merrill Lynch is listed as the broker handling the transaction, with the shares traded on the NYSE under CUSIP 797172829.

When is the proposed sale date for the Colgate-Palmolive (CL) shares?

The proposed sale date stated is August 4, 2026. This date applies both to the exercise of the employee stock options and to the related broker-assisted cashless sale of Colgate-Palmolive common stock covered by the notice.

Which security is involved in Colgate-Palmolive’s (CL) Form 144 transaction?

The security is Colgate-Palmolive common stock, identified by CUSIP 797172829 and listed on the NYSE. The notice covers a proposed resale tied to the exercise of employee stock options through a broker-assisted cashless transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	161021	14800720.47	797172829	08/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/04/2026	Exercise of employee stock options	COLGATE PALMOLIVE CO			161021	08/04/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)